Skip to main content

Advertisement

SpringerLink
Log in

Ovarian Cancer Diagnosed During Pregnancy: Treatment Methods and Coagulation Abnormalities

  • Medicine
  • Published:
SN Comprehensive Clinical Medicine Aims and scope Submit manuscript

Abstract

Malignant tumors affect ~6% of ovarian cancer (OC) patients in early-to-mid-stage pregnancies. Studies reveal that through sessions of ultrasound during pregnancy, early diagnosis and containment become a possibility. Review of primary case studies of patients with OC during pregnancy (both first-time pregnancy and history of miscarriage) suggests that the primary end-goal for the mother is to protect the baby first and foremost. Due to this, the treatment program is designed to cater specific patient’s needs. Yet, on the basis of outcomes of studies, there are three significant treatment/management possibilities which have had successful track record: surgery, systemic chemotherapy/radiotherapy, and chemotherapeutic medications. Coagulation abnormalities in OC patients diagnosed during pregnancies are manifested by a low-grade form of disseminated intravascular coagulation. Such complications may particularly result in damage to the fetus and to the mother also. OC has one of the highest incidence rates of thrombotic events, and hypercoagulability/thrombophilia is a common indicator. Factors that contribute to the activation of coagulation in OC primarily include non-specific mechanisms such as tissue damage, inflammatory responses, and prolonged immobilization, especially during hospitalization. This minireview attempts to provide information on clinical studies which uncover specific treatment procedures in patients with OC compounded by pregnancy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Availability of Data and Material

Not applicable.

Code Availability

Not applicable.

References

  1. Trousseau A. Clinique Médicale de L’hôtel-dieu de Paris: 2nd ed. Volume 3. J.-B. Baillière et fils; Paris, France: 1865. Phlegmatia alba dolens; pp. 654–712.

  2. Abdol Razak NB, Jones G, Bhandari M, Berndt MC, Metharom P. Cancer-associated thrombosis: An overview of mechanisms, risk factors, and treatment. Cancers (Basel). 2018;10(10):380. https://doi.org/10.3390/cancers10100380.

    Article  CAS  Google Scholar 

  3. Rickles FR, Levine M, Edwards RL. Hemostatic alterations in cancer patients. Cancer Metastasis Rev. 1992;11:237–48.

    Article  CAS  PubMed  Google Scholar 

  4. von Tempelhoff GF, Harenberg J, Niemann F, Hommel G, Kirkpatrick CJ, Heilmann L. Effect of low-molecular-weight heparin (Certoparin) versus unfractionated heparin on cancer survival following breast and pelvic cancer surgery: a prospective randomized double-blind trial. Int J Oncol. 2000;16:815–24.

    Google Scholar 

  5. Wojtukiewicz MZ, Zacharski LR, Moritz TE, Hur K, Edwards RL, Rickles FR. Prognostic significance of blood coagulation tests in carcinoma of the lung and colon. Blood Coagul Fibrinolysis. 1992;3:429–37.

    Article  CAS  PubMed  Google Scholar 

  6. Levitan N, Dowlati A, Remick SC, Tahsildar HI, Sivinski LD, Beyth R, et al. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy: risk analysis using Medicare claims data. Medicine (Baltimore). 1999;78:285–91.

    Article  CAS  Google Scholar 

  7. Zacharski LR, Ornstein DL. Venous thromboembolism and cancer. N Engl J Med. 2000;343:1338.

    Article  CAS  PubMed  Google Scholar 

  8. Bick RL. Cancer-associated thrombosis. N Engl J Med. 2003;349:109–11.

    Article  CAS  PubMed  Google Scholar 

  9. Kakkar AK, Levine MN, Pinedo HM, Wolff R, Wong J. Venous thrombosis in cancer patients: Insights from the FRONTLINE survey. Oncologist. 2003;8:381–8.

    Article  PubMed  Google Scholar 

  10. Kakkar AK, Levine MN. Thrombosis and cancer: implications beyond Trousseau. J Thromb Haemost. 2004;2:1261–2.

    Article  CAS  PubMed  Google Scholar 

  11. Kakkar AK, Levine MN, Kadziola Z, Lemoine NR, Low V, Patel HK, et al. Low-molecular-weight heparin therapy with dalteparin and survival in advanced cancer: the Fragmin Advanced Malignancy Outcome Study (FAMOUS). J Clin Oncol. 2004;22:1944–8.

    Article  CAS  PubMed  Google Scholar 

  12. Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021;71:7–33.

    Article  PubMed  Google Scholar 

  13. Palmer J, Vatish M, Tidy J. Epithelial ovarian cancer in pregnancy: a review of the literature. BJOG. 2009;116:480–91.

    Article  CAS  PubMed  Google Scholar 

  14. Paternoster D, Maggino T, Valvente S, Paternoster A, Pengo V, Marchesoni D. Fibrinogen degradation products (FDP) in ascitic fluid of patients affected by ovarian cancer. Clin Exp Obstet Gynecol. 1981;8:64–5.

    CAS  PubMed  Google Scholar 

  15. von Tempelhoff GF, Dietrich M, Niemann F, Schneider D, Hommel G, Heilmann L. Blood coagulation and thrombosis in patients with ovarian malignancy. Thromb Haemost. 1997;77:456–61.

    Article  Google Scholar 

  16. von Tempelhoff GF, Niemann F, Schneider DM, Kirkpatrick CJ, Hommel G, Heilmann L. Blood rheology during chemotherapy in patients with ovarian cancer. Thromb Res. 1998;90:73–82.

    Article  Google Scholar 

  17. Metcalf RL, Fry DJ, Swindell R, McGurk A, Clamp AR, Jayson GC, et al. Thrombosis in ovarian cancer: a case control study. Br J Cancer. 2014;110:1118–24.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Rodriguez AO, Wun T, Chew H, Zhou H, Harvey D, White RH. Venous thromboembolism in ovarian cancer. Gynecol Oncol. 2007;105:784–90.

    Article  PubMed  Google Scholar 

  19. Cardonick E, Iacobucci A. Use of chemotherapy during human pregnancy. Lancet Oncol. 2004;5:283–91.

    Article  CAS  PubMed  Google Scholar 

  20. Farahmand SM, Marchetti DL, Asirwatham JE, Deway MR. Ovarian endodermal sinus tumor associated with pregnancy: review of the literature. Gynecol Oncol. 1991;41:156–60.

    Article  CAS  PubMed  Google Scholar 

  21. Amant F, Berveiller P, Boere IA, Cardonick E, Fruscio R, Fumagalli M, et al. Gynecologic cancers in pregnancy: guidelines based on a third international consensus meeting. Ann Oncol. 2019;30:1601–12.

    Article  CAS  PubMed  Google Scholar 

  22. Whitecar MP, Turner S, Higby MK. Adnexal masses in pregnancy: a review of 130 cases undergoing surgical management. Am J Obstet Gynecol. 1999;181:19–24.

    Article  CAS  PubMed  Google Scholar 

  23. Kwon YS, Mok JE, Lim KT, Lee I-H, Kim T-J, Lee K-H, et al. Ovarian cancer during pregnancy: clinical and pregnancy outcome. J Korean Med Sci. 2010;25:230–4.

    Article  PubMed  PubMed Central  Google Scholar 

  24. McKenzie ND, Kennard JA, Ahmad S. Fertility preserving options for gynecologic malignancies: a review of current understanding and future directions. Crit Rev Oncol Hematol. 2018;132:116–24.

    Article  PubMed  Google Scholar 

  25. Ji Y, Kim KT. Gynecologic malignancy in pregnancy. Obstet Gynecol Sci. 2013;56:289–300.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Antonelli NM, Dotters DJ, Katz VL, Kuller JA. Cancer in pregnancy: a review of the literature. Obstet Gynecol Surv. 1996;51:125–34.

    Article  CAS  PubMed  Google Scholar 

  27. Amant F, Vandenbroucke T, Verheecke M, Fumagalli M, Halaska MJ, Boere I, et al. Pediatric outcome after maternal cancer diagnosed during pregnancy. N Engl J Med. 2015;373:1824–34.

    Article  CAS  PubMed  Google Scholar 

  28. Maggen C, Wolters VERA, Cardonick E, Fumagalli M, Halaska MJ, Lok CAR, et al. International Network on Cancer, Infertility and Pregnancy (INCIP). Pregnancy and cancer: the INCIP Project. Curr Oncol Rep. 2020;22(2):17. https://doi.org/10.1007/s11912-020-0862-7.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Patankar S, Burke WM, Hou JY, Tergas AI, Huang Y, Ananth CV, et al. Risk stratification and outcomes of women undergoing surgery for ovarian cancer. Gynecol Oncol. 2015;138:62–9.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Hummeida ME, Hamad K, Abdel Gadir AF, Ali AA. Ovarian cancer during pregnancy: a case report and literature review. Clin Pract. 2015;5(2):727–34. https://doi.org/10.4081/cp.2015.727.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Xu T, Wang L, Jia Y, Jia Z, Li Z, Cui S, et al. Long-term multidisciplinary integrative therapy management resulted in favorable outcomes for ovarian cancer during pregnancy: a case report and literature review. J Ovarian Res. 2019;12(1):108. https://doi.org/10.1186/s13048-019-0584-3.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Esposito S, Tenconi R, Preti V, Groppali E, Principi N. Chemotherapy against cancer during pregnancy: a systematic review on neonatal outcomes. Medicine (Baltimore). 2016;95(38):e4899. https://doi.org/10.1097/MD.0000000000004899.

    Article  CAS  Google Scholar 

  33. Zheng X, Zhu Y, Zhao Y, Feng S, Zheng C. Taxanes in combination with platinum derivatives for the treatment of ovarian cancer during pregnancy: a literature review. Int J Clin Pharmacol Ther. 2017;55:753–60.

    CAS  PubMed  Google Scholar 

  34. Husz V, Bus D, Vajda G. Extremely large epithelial ovarian cancer associated with pregnancy: a case report. Mol Clin Oncol. 2018;8(1):103–6.

    PubMed  Google Scholar 

  35. Reid BM, Permuth JB, Sellers TA. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14:9–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Dobashi M, Isonishi S, Morikawa A, Takahashi K, Ueda K, Umezawa S, et al. Ovarian cancer complicated by pregnancy: analysis of 10 cases. Oncol Lett. 2012;3:577–80.

    Article  PubMed  Google Scholar 

  37. Hess CW, Peaceman A, O’Brien WT, Winkel CA, Cruikshank DP, Morrison JC. Adnexal masses occurring with intrauterine pregnancy: report of fifty-four patients requiring laparotomy for definitive management. Am J Obstet Gynecol. 1988;158:1029–34.

    Article  CAS  PubMed  Google Scholar 

  38. Ponticelli C, Gabriella M. Fetal toxicity of immunosuppressive drugs in pregnancy. J Clin Med. 2018;7(12):552. https://doi.org/10.3390/jcm7120552.

    Article  PubMed Central  Google Scholar 

  39. Picone O, L'homme C, Tournaire M, Pautier P, Camatte S, Vacher-Lavenue MC, et al. Preservation of pregnancy in a patient with a stage IIIB ovarian epithelial carcinoma diagnosed at 22 weeks of gestation and treated with initial chemotherapy: Case report and literature review. Gynecol Oncol. 2004;94:600–4.

    Article  PubMed  Google Scholar 

  40. Silverstein J, Post AL, Chien AJ, Olin R, Tsai KK, Ngo Z, et al. Multidisciplinary management of cancer during pregnancy. JCO Oncol Pract. 2020;16:545–57.

    Article  PubMed  Google Scholar 

  41. Ni Mhuireachtaigh R, O'Gorman DA. Anesthesia in pregnant patients for non-obstetric surgery. J Clin Anesth. 2006;18:60–6.

    Article  CAS  PubMed  Google Scholar 

  42. Modares GM, Karimi ZM. Preservation of pregnancy in a patient with advanced ovarian cancer at 20 weeks of gestation: case report and review of literature. Int J Gynecol Cancer. 2007;27:1140–3.

    Article  Google Scholar 

  43. Cohen-Kerem R, Railton C, Oren D, Lishner M, Koren G. Pregnancy outcome following non-obstetric surgical intervention. Am J Surg. 2005;190:467–73.

    Article  PubMed  Google Scholar 

  44. Duncan PG, Pope WD, Cohen MM, Greer N. Fetal risk of anesthesia and surgery during pregnancy. Anesthesiology. 1986;64:790–4.

    Article  CAS  PubMed  Google Scholar 

  45. Balinskaite V, Bottle A, Sodhi V, Rivers A, Bennett PR, Brett SJ, et al. The risk of adverse pregnancy outcomes following non-obstetric surgery during pregnancy. Ann Surg. 2017;266:260–6.

    Article  PubMed  Google Scholar 

  46. Moran BJ, Yano H, Al Zahir N, Farquharson M. Conflicting priorities in surgical intervention for cancer in pregnancy. Lancet Oncol. 2007;8:536–44.

    Article  PubMed  Google Scholar 

  47. Post RJ, Friedrich E, Amaya KE, Chmait RH. Inadvertent perforation of a gravid uterus during laparoscopy. JSLS. 2019;23(3):e2019.00026.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Amant F, Han SN, Gziri MM, Dekrem J, van Calsteren K. Chemotherapy during pregnancy. Curr Opin Oncol. 2012;24:580–6.

    Article  CAS  PubMed  Google Scholar 

  49. Huang CY, Cheng M, Lee NR, Huang HY, Lee WL, Chang W-H, et al. Comparing paclitaxel-carboplatin with paclitaxel-cisplatin as the front-line chemotherapy for patients with FIGO IIIC serous-type tubo-ovarian cancer. Int J Environ Res Public Health. 2020;17(7):2213. https://doi.org/10.3390/ijerph17072213.

    Article  CAS  PubMed Central  Google Scholar 

  50. Loibl S, Han SN, von Minckwitz G, Bontenbal M, Ring A, Giermek J, et al. Treatment of breast cancer during pregnancy: an observational study. Lancet Oncol. 2012;13:887–96.

    Article  CAS  PubMed  Google Scholar 

  51. Zemlickus D, Lishner M, Degendorfer P, Panzarella T, Sutcliffe SB, Koren G. Fetal outcome after in utero exposure to cancer chemotherapy. Arch Intern Med. 1992;152:573–6.

    Article  Google Scholar 

  52. Leslie KK, Koil C, Rayburn WF. Chemotherapeutic drugs in pregnancy. Obstet Gynecol Clin N Am. 2005;32:627–40.

    Article  Google Scholar 

  53. van Calsteren K. Chemotherapy during pregnancy: pharmacokinetics and impact on foetal neurological development. Facts Views Vis Obstet Gynecol. 2010;2:278–86.

    Google Scholar 

  54. Peccatori F, Martinelli G, Gentilini O, Goldhirsch A. Chemotherapy during pregnancy: what is really safe? Lancet Oncol. 2004;5(7):398. https://doi.org/10.1016/S1470-2045(04)01506-2.

    Article  PubMed  Google Scholar 

  55. McGowan JV, Chung R, Maulik A, Piotrowska I, Walker JM, Yellon DM. Anthracycline chemotherapy and cardiotoxicity. Cardiovasc Drugs Ther. 2017;31:63–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  56. Reynoso EE, Huerta F. Acute leukemia and pregnancy: fatal outcome after exposure to idarubicin during the second trimester. Acta Oncol. 1994;33:709–10.

    CAS  PubMed  Google Scholar 

  57. Zhang M, Tian Z, Sun Y. Successful treatment of ovarian cancer with apatinib combined with chemotherapy: a case report. Medicine (Baltimore). 2017;96(45):e8570. https://doi.org/10.1097/MD.0000000000008570.

    Article  Google Scholar 

  58. Kim JH, Kim HS, Sung CW, Kim KJ, Kim CH, Lee KY. Docetaxel, gemcitabine, and cisplatin administered for non-small cell lung cancer during the first and second trimester of an unrecognized pregnancy. Lung Cancer. 2008;59:270–3.

    Article  PubMed  Google Scholar 

  59. Zarchi MK, Behtash N, Gilani MM. Good pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for ovarian immature teratoma: a case report and literature review. Arch Gynecol Obstet. 2008;277:75–8.

    Article  Google Scholar 

  60. Woo JC, Yu T, Hurd TC. Breast cancer in pregnancy: a literature review. Arch Surg. 2003;38:91–9.

    Article  Google Scholar 

  61. Karowicz-Bilińska A, Kowalska-Koprek U, Grzesiak M, Pajszczyk-Kieszkiewicz T, Sieroszewski P. Pregnancy and delivery in woman after ovarian cancer treatment: case report. Ginekol Pol. 2002;73(4):364–6 Polish.

    PubMed  Google Scholar 

  62. Michalczyk K, Cymbaluk-Płoska A. Approaches to the diagnosis and management of ovarian cancer in pregnancy. Cancer Manag Res. 2021;13:2329–39.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Grzonka D, Kowalski T, Czarnecki M, Balicz J. Ovarian cancer during pregnancy: two case reports. Wiad Lek. 2002;55:626–9.

    PubMed  Google Scholar 

  64. He S-Y, Shen H-W, Xu L, Li X-L, Yao S-Z. Successful management of mucinous ovarian cancer by conservative surgery in week 6 of pregnancy: case report and literature review. Arch Gynecol Obstet. 2012;286:989–93.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Kaur S, Bodal VK, Bal MS. Malignant mixed germ cell ovarian tumor in pregnant female. Int J Med Dent Sci. 2013;2:233–8.

    Google Scholar 

  66. Eltayeb SM, Al Kalbani MA, Abu Zaid SO, Mubbashir S. Ovarian cancer in early pregnancy, an unusual presentation. Obstet Gynecol Cases Rev. 2014;1(2):006 ISSN: 2377-9004.

    Article  Google Scholar 

  67. Roy P, Biswas B, Thomas S. Epithelial ovarian cancer in pregnancy: report of two cases. Int J Sci Stud. 2014;2:258–61.

    Google Scholar 

  68. Xu D, Liang C, He J. Large malignant ovarian tumors during pregnancy: two cases. Onco Targets Ther. 2014;7:2121–5.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Gynecologic Oncology, AdventHealth Cancer Institute, 2501 N. Orange Ave., Suite 786, Orlando, FL, 32804, USA

    Ahmed Bilal & Sarfraz Ahmad

  2. College of Arts & Sciences, New York University, New York, NY, 10003, USA

    Ahmed Bilal

  3. Florida State University, College of Medicine, Tallahassee, FL, 32306, USA

    Sarfraz Ahmad

  4. University of Central Florida, College of Medicine, Orlando, FL, 32801, USA

    Sarfraz Ahmad

Authors
  1. Ahmed Bilal
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarfraz Ahmad
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors have diligently contributed to the development and preparation of this research manuscript (minireview), including literature search, concept organization, data interpretation, and writings.

Corresponding author

Correspondence to Sarfraz Ahmad.

Ethics declarations

Ethics Approval

Not applicable.

Consent to Participate

Not applicable.

Consent for Publication

All the authors have read and approved the final draft for publication.

Conflict of Interest

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Medicine

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bilal, A., Ahmad, S. Ovarian Cancer Diagnosed During Pregnancy: Treatment Methods and Coagulation Abnormalities. SN Compr. Clin. Med. 3, 2260–2268 (2021). https://doi.org/10.1007/s42399-021-01022-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42399-021-01022-y

Keywords

Search

Navigation